Cyanotech Names Mawae Morton President
KAILUA-KONA, Hawaii (July 17, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that the Board of Directors has named Mawae Morton as President effective... Read More
Investor News
Investor News
Cyanotech Corporation Earns Halal Certification for BioAstin Hawaiian Astaxanthin Raw Material and Vegan Soft Gels
KAILUA-KONA, HAWAII (July 17, 2017) — Cyanotech® Corporation, (Nasdaq Capital Market: CYAN), is proud to announce that its bulk raw material, BioAstin® SCE 5 and... Read More
Cyanotech Reports Financial Results for Fourth Quarter and Fiscal Year 2017
KAILUA-KONA, Hawaii (June 22, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results... Read More
Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal Year 2017
KAILUA-KONA, Hawaii (February 7, 2017) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, announced financial results for... Read More
Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal Year 2017
— Net sales increase 16% to a record $9.9 million, EPS $0.02 vs. $0.00 — KAILUA-KONA, Hawaii (November 10, 2016) — Cyanotech Corporation (Nasdaq Capital Market:... Read More
Cyanotech Names Nancy Katz as a Director
KAILUA-KONA, Hawaii (October 25, 2016) — The Board of Directors of Cyanotech Corporation (Nasdaq Capital Market: CYAN) has named Nancy Katz as a Director of the... Read More
Cyanotech Corporation Earns Non-GMO Project Verification for BULK SCE BioAstin Natural Astaxanthin Products
KAILUA-KONA, Hawaii–(BUSINESS WIRE)–Cyanotech® Corporation (Nasdaq Capital Market: CYAN), is proud to announce that its bulk raw material BioAstin® SCE products have received Non-GMO Project Verification.... Read More